COVID-19 Safety Precautions: Find the Latest Visitor and Mask Policies. Learn More
Clinical Trials Search
Clinical Trial 20794
Cancer Type: Cutaneous
Study Type: Treatment
NCT#: NCT04975152
Phase: Phase I
Prinicipal Investigator: Ahmad Tarhini
Study Title
Neoadjuvant Cemiplimab in Stage I-II Merkel Cell Carcinoma: Safety and Biomarker Analysis
Summary
Objective
Therapies
Medications
Cemiplimab (); REGN2810 (Cemiplimab)
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
